Coronary disease & ACS

Impact of Complete Revascularization in the ISCHEMIA Trial

J Am Coll CardiolPublished Secondary analysis of the ISCHEMIA randomised trial

Authors' conclusion

The outcomes of an INV strategy may be improved if CR (especially ACR) is achieved.

Study context

Population
Patients with chronic coronary disease without prior CABG randomised to invasive (INV) vs conservative (CON) in ISCHEMIA1,824 INV patients assessed
Comparison
Complete revascularization (anatomic complete revascularization (ACR), functional complete revascularization (FCR)) vs incomplete revascularization in INV; ACR in all INV vs CON
  • INVn = 2,296
  • CONn = 2,498reference
Primary endpoint
CV death or MI
Follow-up
4 years
Methodological detailsinverse probability weighted modeling, multivariable-adjusted, independent core laboratory, ACR and FCR assessed at an independent core laboratory
  • Inverse probability weighted modeling
  • Multivariable-adjusted
  • Independent core laboratory
  • ACR and FCR assessed at an independent core laboratory

Primary result

As reported in the abstract

INV vs CONDifference (95% CI)
ACR in all INV patients, inverse probability weighted
−3.5(−7.2% to 0.0%)
Overall ISCHEMIA trial
event rate difference −2.4%

Original publication

Impact of Complete Revascularization in the ISCHEMIA Trial. J Am Coll Cardiol. Published 17 July 2023. doi:10.1016/j.jacc.2023.06.015

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.